Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations

被引:44
作者
Grignon, Sylvain
Chianetta, Jean Marc
机构
[1] Univ Sherbrooke, Sch Med, Dept Psychiat, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Sch Med, Dept Physiol, Sherbrooke, PQ J1H 5N4, Canada
关键词
malondialdehyde (MDA); meta-analysis; oxidative; peroxidation; redox; schizophrenia; thiobarbituric acid reactive substances (TBARS);
D O I
10.1016/j.pnpbp.2006.09.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oxidative stress has long been suggested to participate in the pathophysiology of schizophrenia. Most of the published data on the subject rely on malondialdchyde levels assessment through thiobarbituric acid reactive substances (TBARS), despite significant methodological concerns. The present paper reports on a meta-analysis of studies published up to July 2006. Relevant studies were identified through PubMed search and the References section of experimental and review papers on the subject. Studies were retained for analysis if they provided adequate methods description, controls and subjects numbers, means and standard deviations. Using a random effect model, an effect size of 1.22 (CI: 0.64-1.80) ;was found, with significant bias and high heterogeneity. Inspection of the bias assessment plot suggested a lower value in the order of d approximate to 0. 5, in line with the results of the larger studies. The heterogeneity of the results appeared to be unrelated to assay type or biological sample. However a meta-regression analysis suggested an association, at trend level, between the precision-weighted effect size and the proportion of drug-free patients, which might therefore account for some of the heterogeneity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 40 条
[1]   The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients The possible role of oxidant/antioxidant imbalance [J].
Akyol, Ö ;
Herken, H ;
Uz, E ;
Fadillioglu, E ;
Ünal, S ;
Sögüt, S ;
Özyurt, H ;
Savas, HA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05) :995-1005
[2]   Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients [J].
Altuntas, I ;
Aksoy, H ;
Coskun, I ;
Çayköylü, A ;
Akçay, F .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (12) :1277-1281
[3]   Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia [J].
Arvindakshan, M ;
Ghate, M ;
Ranjekar, PK ;
Evans, DR ;
Mahadik, SP .
SCHIZOPHRENIA RESEARCH, 2003, 62 (03) :195-204
[4]   Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients [J].
Arvindakshan, M ;
Sitasawad, S ;
Debsikdar, V ;
Ghate, M ;
Evans, D ;
Horrobin, DF ;
Bennett, C ;
Ranjekar, PK ;
Mahadik, SP .
BIOLOGICAL PSYCHIATRY, 2003, 53 (01) :56-64
[5]   Factors associated with oxidative stress in human populations [J].
Block, G ;
Dietrich, M ;
Norkus, EP ;
Morrow, JD ;
Hudes, M ;
Caan, B ;
Packer, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (03) :274-285
[6]   Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia [J].
Brown, K ;
Reid, A ;
White, T ;
Henderson, T ;
Hukin, S ;
Johnstone, C ;
Glen, A .
BIOLOGICAL PSYCHIATRY, 1998, 43 (12) :863-867
[7]   Oxidative damage and schizophrenia: The potential benefit by atypical antipsychotics [J].
Dakhale, G ;
Khanzode, S ;
Khanzode, S ;
Saoji, A ;
Khobragade, L ;
Turankar, A .
NEUROPSYCHOBIOLOGY, 2004, 49 (04) :205-209
[8]   Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia [J].
Dakhale, GN ;
Khanzode, SD ;
Khanzode, SS ;
Saoji, A .
PSYCHOPHARMACOLOGY, 2005, 182 (04) :494-498
[9]   Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia [J].
Das, I ;
Ramchand, CN ;
Gliddon, A ;
Hirsch, SR .
NEUROPSYCHOBIOLOGY, 1998, 37 (02) :65-67
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188